Association of vitamin C, vitamin D, vitamin E and risk of bladder cancer: a dose-response meta-analysis
Scientific Reports 5, Article number: 9599 doi:10.1038/srep09599
Fuqiang Chen, Qingshu Li, Yang Yu, Wenrong Yang, Fei Shi & Yan Qu
Received 22 September 2014 Accepted 11 March 2015 Published 23 April 2015
A dose-response meta-analysis was conducted to assess the association of vitamin C, D, E with risk of bladder cancer. Pertinent studies were identified in PubMed and Embase. The random-effect model was used. The relative risk (95% confidence interval) of bladder cancer was 0.99 (0.95–1.03) for every 100 IU/day increment in vitamin D from diet plus supplement and 0.95 (0.90–1.00) for every 10 nmol/L increment in circulating vitamin D.
The effect for every 10 mg/day increment was 0.96 (0.90–1.02) for vitamin E from diet plus supplement, 0.83 (0.72–0.95) from diet and 0.88 (0.67–1.15) from supplement, and the effect was 0.84 (0.76–0.94) for every 1 mg/dL increment in circulating α-Tocopherol and 1.22 (1.00–1.49) for every 0.1 mg/dL increment in circulating γ-Tocopherol. The observed association for vitamin D and vitamin E was significant among smokers but not among non-smokers.
No significant association was found between vitamin C and risk of bladder cancer in the dose-response analysis. Based on the dose-response analysis, the risk of bladder cancer might be inversely associated with vitamin D and E (especially α-Tocopherol), but positively associated with γ-Tocopherol.
- Bladder cancer 25 percent less likely if have high vitamin D – meta-analysis Oct 2014 same conclusion by an earlier meta-analysis
- Bladder cancer 60 percent less likely if have high vitamin D – meta-analysis Dec 2015
- All items in category Bladder Cancer Vitamin D
25 itemsBladder cancer 25 percent less likely if have high vitamin D – meta-analysis April 2015 3236 visitors, last modified 24 Dec, 2015,This page is in the following categories (# of items in each category)